Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.Published in:2019By:Esparza-López, José;Alvarado-Muñoz, Juan Francisco;Escobar-Arriaga, Elizabeth;Ulloa-Aguirre, Alfredo;de Jesús Ibarra-Sánchez, MaríaPublication type:journal article